Advaxis, Inc. (ADXS) Financials

ADXS Assets vs Liabilities

DateAssetsLiabilities
2023-10-31 7.0 million 13.2 million
2023-07-31 12.2 million 11.1 million
2023-04-30 21.0 million 11.3 million
2023-01-31 25.9 million 2.3 million

ADXS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-10-31 -7.0 million 89000
2023-07-31 -7.0 million 89000
2023-04-30 -6.7 million 1.2 million
2023-01-31 -2.8 million 23000

ADXS Net Income

No data available :(

ADXS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-10-31 2.1 million - -
2023-07-31 7.1 million - 1.4 million
2023-04-30 16.8 million - 1.5 million
2023-01-31 25.2 million - 1.7 million

ADXS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-10-31 4.8 million
2023-07-31 4.8 million
2023-04-30 4.4 million
2023-01-31 1.8 million

ADXS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-10-31 - 5.7 million 1.4 million -
2023-07-31 - 5.7 million 2.8 million -
2023-04-30 - 7.3 million 4.6 million -
2023-01-31 201000 2.2 million 2.6 million -

ADXS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-10-31 - 7.1 million
2023-07-31 9000 9000
2023-04-30 4000 4000
2023-01-31 250000 91000

ADXS

Price: $0.56

52 week price:
0.50
1.95

Payout Ratio Range:
-14.45%
-0.40%

Earnings Per Share: -2.51 USD

P/E Ratio: -0.34

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Volume: 5364

Ebitda: -27.5 million

Market Capitalization: 25.9 million

Links: